Nicole Morse - Manager, HTA and Clinical Evaluation
MSc Pathology and Molecular Medicine, Queens University
Nicole Morse is a Manager, HTA and Clinical Evaluation at PDCI. Her role involves analyzing and summarizing scientific information to support the clinical components of pricing and reimbursement submissions and market access assessments.
Nicole brings with her over 3 years of clinical and basic research experience. Prior to joining PDCI, she was working on her Master’s thesis, which focused on investigating the metabolic profile of prostate cancer. Through this experience, she has gained a wide breadth of knowledge in cancer biology and cancer therapeutics. Nicole completed both her Bachelor of Science in Life Science and her Master of Science in Pathology and Molecular Medicine at Queen’s University.